Leadership: Page 30

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New healthcare-related products, services, and companies PhRMA Adopts Clinical-Trial Principles Voluntary principles describe the relationship of PhRMA companies with others involved in clinical research and establish the rules to protect the safety of research participants. The Pharma...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...

    By PharmaVoice Team • Jan. 2, 2008
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive Appointments and Promotions in the Healthcare Industry Featured Talent: Pharma POOL Michael D. Kishbauch, Achillion Pharmaceuticals Kee Moore, STADA Pharmaceuticals Luis Vélez, STADA Pharmaceuticals Dr. Michael Shalmi, Novo Nordisk Biotech POOL Katrine Bosley, Compound Therapeutics ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool Executive Appointments and Promotions Pharma POOL Michael D. Kishbauch Achillion Appoints CEO Achillion Pharmaceuticals has named Michael D. Kishbauch CEO. Mr. Kishbauch replaces Marios Fotiadis, who was acting as interim CEO. Before joining Achillion, New Haven, Conn., Mr. Kishbauch ...

    By PharmaVoice Team • Jan. 2, 2008